The Porter Value Framework Harvard Business School economist Michael E. Porter argues that the definition and demonstration of value are integral to reining in costs and to overall health care reform. He states, “the absence of ...
Wolfson AH, Brady MF, Rocereto TF, et al. A Gynecologic Oncology Group radomized trial of whole abdominal irradiation (WWAI) vs.cisplatin-ifosfamide + mesna (WCIM) in optimally debulked stage I—IV carcinosarcoma (WCS) of the uterine ...
New chapters in this edition cover laparoscopic surgery and national strategies for gynecologic cancer. More than 30 percent of the chapters have been completely rewritten. This edition also includes new full-color illustrations
Sect. I: Etiology, prevention, and molecular biology -- Epidemiology of gynecologic cancers -- Molecular pathogenesis of gynecologic cancers -- Hereditary gynecologic cancers -- Invasion, metastasis, and angiogenesis -- Development and ...
A significant portion of this edition focuses on monoclonal antibodies, vaccines, and gene directed therapies and how they can greatly improve treatment outcomes. A new chapter on end-of-life care is also included.
Principles and Practice of Gynecologic Oncology
Providing comprehensive coverage of the biology of gynecologic cancer, the therapeutic modalities available, and the diagnosis and treatment of site-specific malignancies, this edition has 30 percent new contributing authors and new ...
Principles and Practice of Gynecologic Oncology
Completely reorganized to be more clinically focused on diagnosis and treatment, Principles and Practice of Gynecologic Oncology, Eighth Edition, provides the up-to-date information practitioners, researchers, and students need in an easily ...